Form 4: Hartford President Sells Shares After Option Exercise

Sentiment:

Insider Transaction Report


Hartford Insurance Group President Adin M. Tooker exercised stock options and subsequently sold 6,731 shares of common stock under a pre-arranged trading plan.

Summary

  • Adin M. Tooker, President of Hartford Insurance Group, Inc. (HIG), engaged in an insider transaction on November 26, 2025.
  • Mr. Tooker exercised 6,731 stock options at a price of $48.89 per share.
  • Concurrently, he sold 6,731 shares of common stock at a price of $137.9 per share.
  • The transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on August 25, 2025.
  • Following these transactions, Mr. Tooker's direct beneficial ownership of common stock decreased to 31,721.067 shares.
  • Mr. Tooker continues to hold various stock options with exercise prices ranging from $49.01 to $116.41, and expiration dates extending up to February 25, 2035.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While an insider sale can sometimes be viewed negatively, the transaction was pre-planned under Rule 10b5-1, indicating a routine compensation event rather than a reaction to new information. The significant gain realized by the executive also reflects positively on the company's stock performance.

Positives

  • The executive realized a significant gain from the exercise and sale of options, indicating appreciation in the company's stock value.
  • The transaction was conducted under a Rule 10b5-1 trading plan, demonstrating adherence to corporate governance best practices and mitigating concerns about opportunistic insider trading.

Negatives

  • An executive selling shares, even under a pre-arranged plan, could be perceived by some investors as a lack of confidence, although this is a common practice for compensation realization and diversification.

Risks

  • Potential negative market perception if investors misinterpret the sale as a lack of confidence, despite the 10b5-1 plan.

Future Outlook

This filing does not provide forward-looking statements or guidance regarding the company's future performance or strategic direction. It solely reports an insider transaction.

Industry Context

This is a routine insider transaction for an executive at a publicly traded insurance company. Such transactions are common for executives to realize value from their compensation packages, which often include stock options. The use of a Rule 10b5-1 plan is standard practice in the financial industry to manage insider trading compliance.

Comparison to Industry Standards

  • The use of a Rule 10b5-1 trading plan aligns with best practices for insider transactions in the financial services industry, ensuring transparency and mitigating concerns about trading on material non-public information.
  • The realization of value from stock options is a common form of executive compensation across all industries, including insurance, and reflects the executive's participation in the company's stock performance.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Trading Plan AdoptionMr. Tooker adopted a Rule 10b5-1 trading plan on August 25, 2025, which pre-arranged the reported stock option exercise and subsequent sale of common stock.2025-08-25Enhances corporate governance by providing an affirmative defense against insider trading allegations for pre-scheduled transactions, promoting transparency and compliance.

Stakeholder Impact

  • Shareholders: The transaction is a routine insider sale under a pre-arranged plan, unlikely to have a significant direct impact on shareholders. It reflects an executive realizing value from their compensation.
  • Employees: No direct impact on employees is indicated by this filing.

Key Dates

DateDescription
2020-02-28Options with an exercise price of $48.89 became fully exercisable.
2021-02-27Options with an exercise price of $53.81 became fully exercisable.
2022-02-26Options with an exercise price of $49.01 became fully exercisable.
2023-02-25Options with an exercise price of $55.27 became fully exercisable.
2024-02-23Options with an exercise price of $51.87 became fully exercisable.
2024-02-28One-third of options with an exercise price of $78.28 became exercisable.
2025-02-23Options with an exercise price of $69.41 became fully exercisable.
2025-02-27One-third of options with an exercise price of $95.74 became exercisable.
2025-08-25Mr. Tooker adopted the Rule 10b5-1 trading plan.
2025-11-26Transaction date for option exercise and common stock sale.
2025-12-01Signature date of the Form 4 filing.
2026-02-25One-third of options with an exercise price of $116.41 will become exercisable.
2026-02-27An additional one-third of options with an exercise price of $95.74 will become exercisable.
2026-02-28The remaining one-third of options with an exercise price of $78.28 will become exercisable.
2027-02-25An additional one-third of options with an exercise price of $116.41 will become exercisable.
2027-02-27The remaining one-third of options with an exercise price of $95.74 will become exercisable.
2027-02-28Expiration date for options with an exercise price of $48.89.
2028-02-25The remaining one-third of options with an exercise price of $116.41 will become exercisable.
2028-02-27Expiration date for options with an exercise price of $53.81.
2029-02-26Expiration date for options with an exercise price of $49.01.
2030-02-25Expiration date for options with an exercise price of $55.27.
2031-02-23Expiration date for options with an exercise price of $51.87.
2032-02-23Expiration date for options with an exercise price of $69.41.
2033-02-28Expiration date for options with an exercise price of $78.28.
2034-02-27Expiration date for options with an exercise price of $95.74.
2035-02-25Expiration date for options with an exercise price of $116.41.

Keywords

Insider Trading, Form 4, Stock Options, Executive Compensation, Rule 10b5-1, Hartford Insurance Group, HIG, Adin M. Tooker, Share Sale

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.